Again, h-TERC mRNA levels in the patients with IPF were significantly lower compared with those in the controls (p=0.0005) and patients with NSCLC (p=0.0004) (Table IVA, Fig. 1). The gene discussed is TERC; the disease is non-small cell lung carcinoma.